News / Events
Home/News/Events/News / Events/Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study

Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study

UPDATE : 2019/09/12
The VCRO's partner completed the phase I clinical trial and the trial report was successfully approved by TFDA recently. Congratulations to them, a phase II cell therapy clinical trial was granted by TFDA  on 2019/09/11. It was a phase II cell therapy drug trial for chronic stroke used for IND-registration. VCRO has been providing a full range of services in the field of cell therapy to help partners achieve new drug R&D milestones. Our partner have granted by the authorities and VCRO was deeply honored!

Reference
 
舞狮争霸走势图 足球比分直播网站 快播东京热电影 快乐12四川快乐1 福彩p62最新开奖 卡通三级片图片 幸运快三最新开奖结果 华东联网15选五超长版 led体育比分管理软件 网游湖南亲友棋牌 快乐赛车下载手机版 尼克斯最近比赛比分 山东十一选五最新开 pk10网址 合肥红灯区2019 老快3开奖号码遗漏 浙江20选5每周